11/22/24 18:16 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | M.ad | 0 | 0.00 | 0 | 5 | 4 | 120 | D | | | | | | | | | | | | | | |
11/21/24 18:30 | 11/19/24 | ORKA | Oruka Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fairmount Funds Management LLC | PA | DT | | M.d | 0 | 0.00 | 0 | 160 | 5 | 3,372 | I | | | | | | | | | | | | | | |
11/19/24 16:39 | 11/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -812 | 81.20 | 0 | -10 | -9 | 103 | D | | | | | | | | | | | | | | |
11/18/24 17:36 | 11/14/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -159 | 79.65 | 0 | -2 | -2 | 97 | D | | | | | | | | | | | | | | |
11/12/24 17:41 | 11/8/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -1,001 | 87.16 | 0 | -11 | -2 | 611 | D | | | | | | | | | | | | | | |
11/12/24 08:01 | 11/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marucci Anthony S | NJ | DO | P,CEO | P | 308 | 26.82 | 0 | 12 | 40 | 40 | D | | | | | | | | | | | | | | |
10/29/24 14:06 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 31 | 7 | D | | | | | | | | | | | | | | |
10/29/24 14:04 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 7 | 27 | D | | | | | | | | | | | | | | |
10/29/24 14:01 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 31 | 7 | D | | | | | | | | | | | | | | |
10/29/24 13:58 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 16 | 13 | D | | | | | | | | | | | | | | |
10/29/24 13:56 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 43 | 6 | D | | | | | | | | | | | | | | |
10/29/24 13:26 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 43 | 6 | D | | | | | | | | | | | | | | |
10/29/24 13:23 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | MI | D | | M.d | 25 | 13.81 | 0 | 2 | 7 | 25 | D | | | | | | | | | | | | | | |
10/29/24 13:19 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 25 | 13.81 | 0 | 2 | 6 | 31 | D | | | | | | | | | | | | | | |
10/29/24 13:15 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 131 | 13.81 | 0 | 9 | 66 | 24 | D | | | | | | | | | | | | | | |
10/29/24 13:11 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | M.d | 214 | 13.81 | 0 | 16 | 66 | 39 | D | | | | | | | | | | | | | | |
10/29/24 13:06 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 214 | 13.81 | 0 | 16 | 28 | 71 | D | | | | | | | | | | | | | | |
10/29/24 13:01 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 535 | 13.81 | 0 | 39 | 19 | 246 | D | | | | | | | | | | | | | | |
10/15/24 12:07 | 10/14/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 4 | 14.43 | 0 | 0 | 2 | 17 | D | | | | | | | | | | | | | | |
10/15/24 12:00 | 10/14/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 11 | 14.43 | 0 | 1 | 1 | 60 | D | | | | | | | | | | | | | | |
10/15/24 11:51 | 10/14/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 44 | 14.43 | 0 | 3 | 1 | 219 | D | | | | | | | | | | | | | | |
10/15/24 09:21 | 10/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D | | | | | | | | | | | | | | |
10/11/24 17:23 | 10/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | S | -344 | 22.93 | 0 | -15 | -2 | 962 | D | | | | | | | | | | | | | | |
10/9/24 13:48 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 136 | 15.07 | 0 | 9 | 115 | 17 | D | | | | | | | | | | | | | | |
10/9/24 13:42 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 195 | 15.07 | 0 | 13 | 28 | 60 | D | | | | | | | | | | | | | | |
10/9/24 13:35 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 496 | 15.07 | 0 | 33 | 19 | 202 | D | | | | | | | | | | | | | | |
10/9/24 13:29 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D | | M.d | 31 | 15.07 | 0 | 2 | 100 | 4 | D | | | | | | | | | | | | | | |
10/9/24 13:25 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D | | M.d | 31 | 15.07 | 0 | 2 | 100 | 4 | D | | | | | | | | | | | | | | |
10/9/24 13:18 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
10/9/24 12:08 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | | M.d | 35 | 15.05 | 0 | 2 | 68 | 6 | D | | | | | | | | | | | | | | |
10/9/24 12:03 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | M.d | 35 | 15.05 | 0 | 2 | 10 | 26 | D | | | | | | | | | | | | | | |
10/9/24 11:59 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D | | M.d | 35 | 15.05 | 0 | 2 | 68 | 6 | D | | | | | | | | | | | | | | |
10/9/24 11:53 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | M.d | 35 | 15.05 | 0 | 2 | 27 | 11 | D | | | | | | | | | | | | | | |
10/9/24 11:46 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | | D | | M.d | 35 | 15.05 | 0 | 2 | 11 | 24 | D | | | | | | | | | | | | | | |
10/9/24 11:37 | 10/7/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 35 | 15.05 | 0 | 2 | 8 | 29 | D | | | | | | | | | | | | | | |
10/8/24 10:42 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/7/24 11:29 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
10/4/24 17:29 | 10/2/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | S | -38 | 19.01 | 0 | -2 | -4 | 47 | D | | | | | | | | | | | | | | |
10/3/24 16:44 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | TX | D | | M.d | 0 | 0.00 | 0 | 5 | 10 | 58 | D | | | | | | | | | | | | | | |
10/2/24 18:05 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | M.d | 0 | 0.00 | 0 | 6 | 11 | 61 | D | | | | | | | | | | | | | | |
10/2/24 17:55 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | M.d | 0 | 0.00 | 0 | 5 | 10 | 56 | D | | | | | | | | | | | | | | |
10/2/24 17:39 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | M.d | 0 | 0.00 | 0 | 8 | 17 | 57 | D | | | | | | | | | | | | | | |
10/2/24 17:31 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | M.d | 0 | 0.00 | 0 | 5 | 4 | 120 | D | | | | | | | | | | | | | | |
10/2/24 17:19 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | M.d | 0 | 0.00 | 0 | 5 | 12 | 46 | D | | | | | | | | | | | | | | |
9/23/24 16:24 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/12/24 16:11 | 9/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | S | -401 | 26.72 | 0 | -15 | -2 | 977 | D | | | | | | | | | | | | | | |
9/12/24 16:09 | 9/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Muzzey Dale | UT | O | Chief Sc | S | -55 | 26.17 | 0 | -2 | -2 | 108 | D | | | | | | | | | | | | | | |
9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I | | | | | | | | | | | | | | |
9/9/24 17:48 | 9/9/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | | S | -271 | 27.05 | 0 | -10 | -8 | 122 | D | | | | | | | | | | | | | | |
9/9/24 11:08 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | O | CTO | P | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/9/24 11:01 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P | 20 | 0.2900 | 0 | 69 | 4 | 1,684 | D | | | | | | | | | | | | | | |
9/4/24 21:13 | 2/2/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | S.a | -107 | 49.54 | 0 | -2 | -2 | 93 | D | | | | | | | | | | | | | | |
9/4/24 20:20 | 9/1/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 22 | 1 | D | | | | | | | | | | | | | | |
9/4/24 20:03 | 9/1/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 4 | 1 | D | | | | | | | | | | | | | | |
9/4/24 19:38 | 9/3/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reitan Colleen F | UT | D | | S | -1,286 | 27.95 | 0 | -46 | -52 | 43 | D | | | | | | | | | | | | | | |
9/3/24 11:41 | 8/29/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | M.d | 69 | 15.47 | 0 | 4 | 105 | 9 | D | | | | | | | | | | | | | | |
8/26/24 13:34 | 8/23/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | M.d | 124 | 15.47 | 0 | 8 | 42 | 27 | D | | | | | | | | | | | | | | |
8/23/24 16:30 | 8/21/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Thrall James H | MA | D | | S | -99 | 98.52 | 0 | -1 | -3 | 34 | D | | | | | | | | | | | | | | |
8/23/24 16:16 | 8/21/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ancona Margaret | UT | O | SVP,Chie | S | -321 | 27.82 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
8/21/24 08:26 | 8/20/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D | | | | | | | | | | | | | | |
8/20/24 16:38 | 8/19/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kumar Rashmi | UT | D | | S | -210 | 28.01 | 0 | -8 | -9 | 77 | D | | | | | | | | | | | | | | |
8/16/24 16:30 | 8/14/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -244 | 97.54 | 0 | -3 | -3 | 78 | D | | | | | | | | | | | | | | |
8/14/24 16:56 | 8/12/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ber Gerard | MA | D | | S | -1,495 | 96.48 | 0 | -16 | -42 | 21 | D | | | | | | | | | | | | | | |
8/12/24 17:09 | 8/8/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -193 | 96.39 | 0 | -2 | -2 | 99 | D | | | | | | | | | | | | | | |
8/7/24 17:01 | 8/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 0 | 49 | D | | | | | | | | | | | | | | |
8/7/24 17:00 | 8/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 0 | 82 | D | | | | | | | | | | | | | | |
8/7/24 10:17 | 8/6/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
8/6/24 16:30 | 8/2/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -1,001 | 95.50 | 0 | -10 | -2 | 623 | D | | | | | | | | | | | | | | |
7/23/24 18:43 | 7/19/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Widder Kenneth J | CA | D | | M.d | 93 | 27.91 | 0 | 3 | 13 | 28 | D | | | | | | | | | | | | | | |
7/17/24 16:30 | 7/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S.m | -266 | 124.67 | 0 | -2 | -3 | 60 | D | | | | | | | | | | | | | | |
7/16/24 21:13 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.24 | 0 | 12,097 | 83 | 26,591 | I | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 50 | 1.24 | 0 | 40 | 46 | 128 | D | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.24 | 0 | 81 | 50 | 243 | D | | | | | | | | | | | | | | |
7/12/24 16:30 | 7/10/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Pruden Gary J | MA | D | | S | -1,191 | 95.04 | 0 | -13 | -35 | 23 | I | | | | | | | | | | | | | | |
7/11/24 17:15 | 7/9/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 7 | 0 | 1,919 | D | | | | | | | | | | | | | | |
7/3/24 13:15 | 7/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -9 | 22.93 | 0 | 0 | -1 | 71 | D | | | | | | | | | | | | | | |
6/20/24 17:00 | 6/17/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Verwiel Frank | MA | D | | S | -38 | 25.00 | 0 | -2 | -8 | 18 | D | | | | | | | | | | | | | | |
6/18/24 16:12 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 29 | 2 | 1,912 | I | | | | | | | | | | | | | | |
6/18/24 16:05 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 205 | 10.16 | 0 | 20 | 254 | 28 | D | | | | | | | | | | | | | | |
6/18/24 16:05 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | S.d | -608 | 35.42 | 0 | -17 | -38 | 28 | D | | | | | | | | | | | | | | |
6/18/24 16:04 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | M.d | 311 | 10.38 | 0 | 30 | | 9 | D | | | | | | | | | | | | | | |
6/18/24 16:04 | 6/14/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | S.d | -1,046 | 34.87 | 0 | -30 | -77 | 9 | D | | | | | | | | | | | | | | |
6/17/24 16:30 | 6/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -27 | 79.77 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
6/13/24 16:05 | 6/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Young Diane C. | NJ | O | SVP,Chie | M.d | 41 | 2.71 | 0 | 15 | 709 | 17 | D | | | | | | | | | | | | | | |
6/11/24 16:02 | 6/7/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | M.d | 145 | 9.70 | 0 | 15 | | 9 | D | | | | | | | | | | | | | | |
6/11/24 16:02 | 6/7/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | S.d | -526 | 35.06 | 0 | -15 | -62 | 9 | D | | | | | | | | | | | | | | |
6/11/24 16:01 | 6/7/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Young Diane C. | NJ | O | SVP,Chie | S | -1,587 | 35.26 | 0 | -45 | -96 | 2 | D | | | | | | | | | | | | | | |
6/7/24 16:05 | 6/5/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | M.d | 99 | 10.38 | 0 | 10 | 37 | 35 | D | | | | | | | | | | | | | | |
6/5/24 16:06 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | M.d | 663 | 10.25 | 0 | 65 | | 13 | D | | | | | | | | | | | | | | |
6/5/24 16:06 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | S.d | -1,964 | 33.65 | 0 | -58 | -81 | 13 | D | | | | | | | | | | | | | | |
6/5/24 16:05 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wright Richard M. | NJ | O | SVP,CCO | M.d | 1,268 | 18.79 | 0 | 67 | | 21 | D | | | | | | | | | | | | | | |
6/5/24 16:05 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wright Richard M. | NJ | O | SVP,CCO | S.d | -1,579 | 33.72 | 0 | -47 | -69 | 21 | D | | | | | | | | | | | | | | |
6/5/24 16:04 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | M.d | 83 | 10.38 | 0 | 8 | 45 | 26 | D | | | | | | | | | | | | | | |
6/5/24 16:04 | 6/3/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | S.d | -269 | 33.60 | 0 | -8 | -24 | 26 | D | | | | | | | | | | | | | | |
6/4/24 17:57 | 6/3/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S.m | -167 | 22.05 | 0 | -8 | -19 | 33 | D | | | | | | | | | | | | | | |
6/3/24 17:30 | 5/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | CEO | P | 23 | 2.42 | 0 | 9 | 16 | 71 | D | | | | | | | | | | | | | | |
6/3/24 16:30 | 5/30/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | S | -1,028 | 79.86 | 0 | -13 | -14 | 80 | D | | | | | | | | | | | | | | |
6/3/24 16:06 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | M.d | 126 | 3.75 | 0 | 34 | | 7 | D | | | | | | | | | | | | | | |
6/3/24 16:06 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heath-Chiozzi Margo | NJ | O | SVP of R | S.d | -1,319 | 34.07 | 0 | -39 | -85 | 7 | D | | | | | | | | | | | | | | |
6/3/24 16:05 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 260 | 10.38 | 0 | 25 | 999% | 25 | D | | | | | | | | | | | | | | |
6/3/24 16:05 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | S.d | -1,192 | 34.05 | 0 | -35 | -58 | 25 | D | | | | | | | | | | | | | | |
6/3/24 16:04 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Sarah | NJ | O | SVP of C | M.d | 121 | 5.80 | 0 | 21 | | 2 | D | | | | | | | | | | | | | | |
6/3/24 16:04 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Sarah | NJ | O | SVP of C | S.d | -703 | 33.73 | 0 | -21 | -92 | 2 | D | | | | | | | | | | | | | | |
6/3/24 16:04 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | M.d | 172 | 4.01 | 0 | 43 | | 9 | D | | | | | | | | | | | | | | |
6/3/24 16:04 | 5/30/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowley Elizabeth | NJ | O | SVP,CPDO | S.d | -1,298 | 33.64 | 0 | -39 | -81 | 9 | D | | | | | | | | | | | | | | |
5/30/24 16:34 | 5/28/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | M.d | 283 | 16.17 | 0 | 17 | 298 | 23 | D | | | | | | | | | | | | | | |
5/30/24 16:34 | 5/28/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Maeusli Heinz Christoph | MA | D | | S.d | -1,455 | 79.19 | 0 | -18 | -44 | 23 | D | | | | | | | | | | | | | | |
5/30/24 16:32 | 5/28/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | S | -196 | 78.50 | 0 | -3 | -8 | 29 | D | | | | | | | | | | | | | | |
5/20/24 17:00 | 5/17/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | S | -108 | 540.80 | 0 | 0 | -10 | 2 | D | | | | | | | | | | | | | | |
5/15/24 17:49 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | S.m | -5,729 | 25.14 | 0 | -228 | -18 | 1,066 | D | | | | | | | | | | | | | | |
5/15/24 17:48 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Newcomer Lee Nisley | UT | D | | S | -157 | 25.30 | 0 | -6 | -9 | 67 | D | | | | | | | | | | | | | | |
5/15/24 17:09 | 5/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -26 | 76.89 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 3 | 10 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 9 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 15 | 2 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Asha | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 49 | 1 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Britt Irene Chang | ME | D | | M.d | 0 | 0.00 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 0 | 578 | D | | | | | | | | | | | | | | |
4/26/24 12:50 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | M.d | 25 | 11.96 | 0 | 2 | 1 | 171 | D | | | | | | | | | | | | | | |
4/26/24 12:38 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | M.d | 10 | 11.96 | 0 | 1 | 2 | 47 | D | | | | | | | | | | | | | | |
4/26/24 09:48 | 4/25/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | M.d | 7 | 11.96 | 0 | 1 | 6 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:39 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wan Jerry | A1 | O | Principa | M.d | 0 | 0.00 | 0 | 6 | 135 | 10 | D | | | | | | | | | | | | | | |
4/23/24 16:35 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jacobs Cindy | WA | DO | P,CMO | M.d | 0 | 0.00 | 0 | 16 | 114 | 31 | D | | | | | | | | | | | | | | |
4/23/24 16:31 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | M.d | 0 | 0.00 | 0 | 23 | 79 | 51 | D | | | | | | | | | | | | | | |
4/23/24 16:26 | 4/19/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | M.d | 0 | 0.00 | 0 | 25 | 35 | 96 | D | | | | | | | | | | | | | | |
4/17/24 16:30 | 4/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 61.24 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/16/24 18:18 | 4/12/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | | M.d | 190 | 21.07 | 0 | 9 | 12 | 84 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
4/8/24 15:28 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Burton Paul Frederick | IL | D | | M.d | 13 | 1.42 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
4/8/24 15:22 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 10 | 100 | D | | | | | | | | | | | | | | |
4/8/24 15:07 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Intrater James | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
4/8/24 14:59 | 3/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Levy Oded | IL | D | | M.d | 13 | 1.42 | 0 | 9 | 14 | 72 | D | | | | | | | | | | | | | | |
3/19/24 16:30 | 3/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | S | -1,200 | 60.00 | 0 | -20 | -15 | 114 | D | | | | | | | | | | | | | | |
3/15/24 16:30 | 3/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -21 | 60.48 | 0 | 0 | -1 | 63 | D | | | | | | | | | | | | | | |
3/11/24 16:30 | 3/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | S | -1,117 | 61.96 | 0 | -18 | -15 | 103 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 3,424 | 422.45 | 0 | 8 | 311 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -4,526 | 558.44 | 0 | -8 | -43 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 345 | 245.79 | 0 | 1 | 18 | 9 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -790 | 562.98 | 0 | -1 | -13 | 9 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.dm | 67 | 16.30 | 0 | 4 | 8 | 58 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.dm | -262 | 64.06 | 0 | -4 | -7 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | M.d | 444 | 19.85 | 0 | 22 | 63 | 58 | D | | | | | | | | | | | | | | |
3/6/24 17:15 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | S.d | -1,465 | 65.42 | 0 | -22 | -28 | 58 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -6,130 | 65.31 | 0 | -94 | -13 | 631 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S.d | -76 | 32.99 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/4/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S.d | -20 | 32.99 | 0 | -1 | -1 | 71 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
2/22/24 17:02 | 2/21/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 206.94 | 0 | 0 | 1 | 82 | D | | | | | | | | | | | | | | |
2/20/24 17:01 | 2/16/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 9 | 6 | D | | | | | | | | | | | | | | |
2/20/24 17:00 | 2/15/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 100 | 206.94 | 0 | 0 | 1 | 49 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 244 | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 88 | 1 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 11 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 4 | 48 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 4 | 5 | 82 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 15 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP,CHRO | M.d | 0 | 0.00 | 0 | 0 | 999% | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 6 | 12 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 0 | 6 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:54 | 2/14/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 5 | 11 | D | | | | | | | | | | | | | | |
2/15/24 16:30 | 2/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 55.31 | 0 | 0 | -1 | 58 | D | | | | | | | | | | | | | | |
2/15/24 16:05 | 2/13/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jimenez Freddy A. | NJ | O | SVP,GC | M.d | 93 | 3.86 | 0 | 24 | 999% | 26 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 608 | 62.00 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | S.d | -4,705 | 573.87 | 0 | -8 | -55 | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 3,303 | 141.60 | 0 | 23 | 95 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | S.d | -13,296 | 570.01 | 0 | -23 | -33 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 814 | 67.85 | 0 | 12 | 18 | 79 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,871 | 572.61 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
2/5/24 16:50 | 1/31/24 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Lau Stanley K. | IL | D | | M.d | 2 | 2.18 | 0 | 1 | 1 | 92 | D | | | | | | | | | | | | | | |
2/2/24 19:55 | 2/2/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | S | -105 | 49.54 | 0 | -2 | -2 | 93 | D | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D | | | | | | | | | | | | | | |
1/18/24 17:48 | 1/16/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | M.d | 0 | 0.00 | 0 | 22 | 33 | 91 | D | | | | | | | | | | | | | | |
1/18/24 17:48 | 1/17/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | S.d | -438 | 50.42 | 0 | -9 | -9 | 91 | D | | | | | | | | | | | | | | |
1/18/24 16:30 | 1/16/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | S | -19 | 56.01 | 0 | 0 | -1 | 59 | D | | | | | | | | | | | | | | |
1/10/24 16:15 | 1/8/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -66 | 28.87 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
1/5/24 16:51 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | S | -566 | 29.46 | 0 | -19 | -2 | 905 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | S | -172 | 29.46 | 0 | -6 | -10 | 54 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | S | -163 | 29.46 | 0 | -6 | -11 | 46 | D | | | | | | | | | | | | | | |
1/5/24 16:49 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | S | -158 | 29.46 | 0 | -5 | -12 | 41 | D | | | | | | | | | | | | | | |
1/5/24 16:46 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | S | -114 | 29.46 | 0 | -4 | -9 | 37 | D | | | | | | | | | | | | | | |
1/5/24 16:45 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | S | -112 | 29.46 | 0 | -4 | -7 | 51 | D | | | | | | | | | | | | | | |
1/5/24 16:44 | 1/3/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | S | -136 | 29.50 | 0 | -5 | -10 | 41 | D | | | | | | | | | | | | | | |
1/4/24 16:05 | 1/2/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Martin Samuel Bates | NJ | O | SVP,CFO | M.d | 30 | 2.78 | 0 | 11 | 44 | 35 | D | | | | | | | | | | | | | | |
1/3/24 17:35 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 7 | 52 | D | | | | | | | | | | | | | | |
1/3/24 17:34 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 3 | 6 | 60 | D | | | | | | | | | | | | | | |
1/3/24 17:30 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 8 | 1 | 924 | D | | | | | | | | | | | | | | |
1/3/24 17:28 | 1/1/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 7 | 46 | D | | | | | | | | | | | | | | |
1/3/24 10:41 | 1/2/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | S | -18 | 0.9000 | 0 | -20 | 0 | 12,005 | I | | | | | | | | | | | | | | |